Search
Patexia Research
Case number 1:21-cv-00566

Bayer Pharma AG et al v. Accord Healthcare Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Jul 29, 2021 13 Order (2)
Docket Text: SO ORDERED Granting [12] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 7/29/2021. (nms)
Jul 29, 2021 14 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (Attachments: # (1) Order)(nms)
Jul 29, 2021 14 Order (2)
Jul 28, 2021 11 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by Kevin M. Capuzzi on behalf of All Defendants (Capuzzi, Kevin)
Jul 28, 2021 12 Stipulation of Dismissal (2)
Docket Text: STIPULATION of Dismissal by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
Jul 19, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [10] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Accord Healthcare Inc. answer due 8/2/2021; Accord Healthcare Limited answer due 8/2/2021; Intas Pharmaceuticals Limited answer due 8/2/2021). Signed by Judge Richard G. Andrews on 7/19/2021. (nms)
Jul 19, 2021 10 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for Defendants Accord Healthcare Inc., Accord Healthcare Limited and Intas Pharmaceuticals Limited to move, answer, or otherwise respond to Plaintiffs' Complaint to August 2, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
Jul 6, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [9] STIPULATION and Proposed Order Extending Time (*Reset Answer Deadlines: Accord Healthcare Inc. answer due 7/19/2021; Accord Healthcare Limited answer due 7/19/2021; Intas Pharmaceuticals Limited answer due 7/19/2021). Signed by Judge Richard G. Andrews on 7/6/2021. (nms)
Jul 6, 2021 9 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION and Proposed Order Extending Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/6/2021 (nms).
May 10, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [8] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Accord Healthcare Inc. answer due 7/5/2021; Accord Healthcare Limited answer due 7/5/2021; Intas Pharmaceuticals Limited answer due 7/5/2021). Signed by Judge Richard G. Andrews on 5/10/2021. (nms)
May 10, 2021 8 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Blumenfeld, Jack) Modified on 5/10/2021 (nms).
Apr 28, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Apr 22, 2021 1 Main Document (12)
Docket Text: COMPLAINT filed against Accord Healthcare Inc., Accord Healthcare Limited, Intas Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3599155.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(apk)
Apr 22, 2021 1 Exhibit A (26)
Apr 22, 2021 1 Civil Cover Sheet (1)
Apr 22, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
Apr 22, 2021 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/9/2021. Date of Expiration of Patent: 01/31/2039. (apk)
Apr 22, 2021 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (apk)
Apr 22, 2021 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer Pharma AG. (apk)
Apr 22, 2021 6 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (apk)
Apr 22, 2021 7 Summons Issued - Electronic (2)
Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (apk)
Apr 22, 2021 1 Complaint* (1)
Menu